Labcorp Holdings Noncontrolling interest remained flat by 0.0% to $16.90M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 18.2%, from $14.30M to $16.90M. Over 5 years (FY 2020 to FY 2025), Noncontrolling interest shows a downward trend with a -4.0% CAGR.
Changes reflect the acquisition or divestiture of minority stakes in joint ventures or changes in the profitability of those specific subsidiaries.
This represents the portion of equity in a subsidiary that is not attributable to the parent company. It reflects the in...
Common for companies that operate through joint ventures or regional partnerships in the healthcare sector.
other_noncontrolling_interest_mezzanine_equity| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $21.00M | $20.60M | $20.60M | $20.60M | $20.00M | $18.90M | $18.90M | $19.30M | $19.80M | $19.40M | $15.50M | $15.20M | $15.00M | $15.20M | $14.30M | $14.30M | $16.70M | $16.10M | $16.90M | $16.90M |
| QoQ Change | — | -1.9% | +0.0% | +0.0% | -2.9% | -5.5% | +0.0% | +2.1% | +2.6% | -2.0% | -20.1% | -1.9% | -1.3% | +1.3% | -5.9% | +0.0% | +16.8% | -3.6% | +5.0% | +0.0% |
| YoY Change | — | — | — | — | -4.8% | -8.3% | -8.3% | -6.3% | -1.0% | +2.6% | -18.0% | -21.2% | -24.2% | -21.6% | -7.7% | -5.9% | +11.3% | +5.9% | +18.2% | +18.2% |